Cargando…

Elevated CRP levels indicate poor progression-free and overall survival on cancer patients treated with PD-1 inhibitors

BACKGROUND: Anti-PD-(L)1 agents are standard of care treatments in various cancers but predictive factors for therapy selection are limited. We hypothesised that markers of systemic inflammation would predict adverse outcomes in multiple cancers treated with anti-PD-(L)1 agents. MATERIAL AND METHODS...

Descripción completa

Detalles Bibliográficos
Autores principales:	Iivanainen, Sanna, Ahvonen, Jarkko, Knuuttila, Aija, Tiainen, Satu, Koivunen, Jussi Pekka
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2019
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6735669/ https://www.ncbi.nlm.nih.gov/pubmed/31555483 http://dx.doi.org/10.1136/esmoopen-2019-000531

Ejemplares similares

The prognostic and predictive roles of plasma C‐reactive protein and PD‐L1 in non‐small cell lung cancer
por: Kuusisalo, Saara, et al.
Publicado: (2023)

Treatment discontinuation and re-initiation of anti-PD-(L)1 agents in metastatic cancers
por: Tikkanen, Antti, et al.
Publicado: (2020)

Tetracyclines increase the survival of NSCLC patients treated with EGFR TKIs: a retrospective nationwide registry study
por: Alanen, Virve, et al.
Publicado: (2020)

Possibilities of Improving the Clinical Value of Immune Checkpoint Inhibitor Therapies in Cancer Care by Optimizing Patient Selection
por: Iivanainen, Sanna, et al.
Publicado: (2020)

Follow-Up of Cancer Patients Receiving Anti-PD-(L)1 Therapy Using an Electronic Patient-Reported Outcomes Tool (KISS): Prospective Feasibility Cohort Study
por: Iivanainen, Sanna, et al.
Publicado: (2020)

Association of Rare Immune-Related Adverse Events to Survival in Advanced Cancer Patients Treated with Immune Checkpoint Inhibitors: A Real-World Single-Center Cohort Study
por: Kuusisalo, Saara, et al.
Publicado: (2022)

Assessment of chemotherapy‐induced neurotoxicity using a point‐of‐care nerve conduction study device
por: Jokimäki, Anna, et al.
Publicado: (2022)

Electronic patient-reported outcomes and machine learning in predicting immune-related adverse events of immune checkpoint inhibitor therapies
por: Iivanainen, Sanna, et al.
Publicado: (2021)

ePROs in the follow-up of cancer patients treated with immune checkpoint inhibitors: a retrospective study
por: Iivanainen, Sanna, et al.
Publicado: (2019)

Previous radiotherapy improves treatment responses and causes a trend toward longer time to progression among patients with immune checkpoint inhibitor-related adverse events
por: Jokimäki, Anna, et al.
Publicado: (2023)

PD-1 and PD-L1 expression in pulmonary carcinoid tumors and their association to tumor spread
por: Vesterinen, Tiina, et al.
Publicado: (2019)

ePRO symptom follow-up of colorectal cancer patients receiving oxaliplatin-based adjuvant chemotherapy is feasible and enhances the quality of patient care: a prospective multicenter study
por: Iivanainen, Sanna, et al.
Publicado: (2023)

Digital Monitoring and Management of Patients With Advanced or Metastatic Non-Small Cell Lung Cancer Treated With Cancer Immunotherapy and Its Impact on Quality of Clinical Care: Interview and Survey Study Among Health Care Professionals and Patients
por: Schmalz, Oliver, et al.
Publicado: (2020)

Prognostic and predictive role of spatially positioned tumour infiltrating lymphocytes in metastatic HER2 positive breast cancer treated with trastuzumab
por: Honkanen, Tiia J., et al.
Publicado: (2017)

Selective Apheresis of C-Reactive Protein for Treatment of Indications with Elevated CRP Concentrations
por: Kayser, Stefan, et al.
Publicado: (2020)

Targeted Resequencing Reveals ALK Fusions in Non-Small Cell Lung Carcinomas Detected by FISH, Immunohistochemistry, and Real-Time RT-PCR: A Comparison of Four Methods
por: Tuononen, Katja, et al.
Publicado: (2013)

The prognostic and predictive role of the neutrophil-to-lymphocyte ratio and the monocyte-to-lymphocyte ratio in early breast cancer, especially in the HER2+ subtype
por: Tiainen, Satu, et al.
Publicado: (2020)

Different Kinetics of Perioperative CRP after Hip Arthroplasty for Elderly Femoral Neck Fracture with Elevated Preoperative CRP
por: Lim, Seung-Jae, et al.
Publicado: (2018)

Elevated CRP levels predict poor outcome and tumor recurrence in patients with thymic epithelial tumors: A pro- and retrospective analysis
por: Janik, Stefan, et al.
Publicado: (2017)

CRP gene variation affects early development of Alzheimer's disease-related plaques
por: Kok, Eloise Helena, et al.
Publicado: (2011)

Correlation between hs-CRP and Asthma Control Indices
por: Sigari, Naseh, et al.
Publicado: (2013)

Hantavirus infection-induced B cell activation elevates free light chains levels in circulation
por: Hepojoki, Jussi, et al.
Publicado: (2021)

Who Is Afraid of CRP? Elevated Preoperative CRP Levels Might Attenuate the Increase in Inflammatory Parameters in Response to Lung Cancer Surgery
por: Meyer, Moritz Mecki, et al.
Publicado: (2020)

High CRP values predict poor survival in patients with penile cancer
por: Steffens, Sandra, et al.
Publicado: (2013)

Waist circumference and waist-to-height ratio are associated with periodontal pocketing—results of the Health 2000 Survey
por: Kangas, Sanna, et al.
Publicado: (2017)

C-Reactive Protein (CRP): A poor prognostic biomarker in COVID-19
por: Bouayed, Mohamed Zakaria, et al.
Publicado: (2022)

Treatment of intracerebellar haemorrhage: Poor outcome and high long-term mortality
por: Satopää, Jarno, et al.
Publicado: (2017)

Monomeric CRP is Elevated in Patients with COPD Compared to Non-COPD Control Persons
por: Munuswamy, Revathy, et al.
Publicado: (2021)

ASCOT analysis with atorvastatin shows limits of CRP as indicator of cardiovascular risk
Publicado: (2011)

Transcriptome-Based Co-Expression of BRD4 and PD-1/PD-L1 Predicts Poor Overall Survival in Patients With Acute Myeloid Leukemia
por: Chen, Cunte, et al.
Publicado: (2021)

CRP in Outpatients with Inflammatory Bowel Disease Is Linked to the Blood Microbiota
por: Xu, Jie, et al.
Publicado: (2023)

Effect of CRP and Kinetics of CRP in Prognosis of Nasopharyngeal Carcinoma
por: Chen, Ruiwan, et al.
Publicado: (2019)

Presence of cancer-associated mutations in exhaled breath condensates of healthy individuals by next generation sequencing
por: Youssef, Omar, et al.
Publicado: (2017)

CRP Genotypes Predict Increased Risk to Co-Present with Low Vitamin D and Elevated CRP in a Group of Healthy Black South African Women
por: Myburgh, Pieter H., et al.
Publicado: (2018)

Increased PD-1(+)Foxp3(+) γδ T cells associate with poor overall survival for patients with acute myeloid leukemia
por: Zheng, Jiamian, et al.
Publicado: (2022)

Association of sleep duration and quality with elevated hs-CRP among healthy Korean adults
por: Lee, Hwi-Won, et al.
Publicado: (2020)

Elevated levels of IL-6 and CRP predict the need for mechanical ventilation in COVID-19
por: Herold, Tobias, et al.
Publicado: (2020)

Elevated PD-L1 expression predicts poor survival outcomes in patients with cervical cancer
por: Gu, Xiaobin, et al.
Publicado: (2019)

Elevated LSD1 and SNAIL Expression Indicate Poor Prognosis in Hypopharynx Carcinoma
por: Bottner, Justus, et al.
Publicado: (2022)

The joint subclinical elevation of CRP and IL-6 is associated with lower health-related quality of life in comparison with no elevation or elevation of only one of the biomarkers
por: Garvin, Peter, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_km0cbo89es2p4pojgj6ir5bsog